Eswara K. Mundra, MD

Eswara K. Mundra, MD

Assistant Professor

Department:
SOM-Radiation/Oncology

Email:
emundra@umc.edu

Work Phone:
(601) 984-2500

Education

University of MS Medical Center, Fellowship in Radiation Oncology, Radiation Oncology2019
Osmania Medical College, MD, Clinical Oncology & Radiation Therapy2005
Siddhartha Medical College, MBBS, MBBS2000

Specialty Certification Licensure

Certification, American Board Certified, American Board of Radiology05/2022 - Present
Licensure, Certificate of License Medication, Mississippi State Board of Medical Licensure07/2022 - 06/2023

Current Positions

Assistant Professor, School of Medicine07/2022 - Present
The University of Mississippi Medical Center
Jackson, Mississippi 39216

Academic Appointments or Other Previous Appointments

Instructor, University of MS Medical Center, School of Medicine, Department of Radiation / Oncology06/2019 - 06/2022
Fellow, University of MS Medical Center, School of Medicine, Department of Radiation / Oncology06/2015 - 05/2018
SMO, Sangre Grande Hospital01/2010 - 04/2015
Registrar in Oncology, Sangre Grande Hospital01/2009 - 01/2010
House Officer, St. James Medical Complex06/2007 - 12/2008
Senior Resident, Nizam's Institute of Medical Sciences11/2006 - 03/2007

Publications

Peer-Reviewed Research Abstracts Published as Proceedings of National Scientific Meetings

Nittala MR, Mundra EK, Packianathan S, Smith ML, Woods WC, Allbright R, Vijayakumar S. Single Institution Experience of Stereotactice Body Radiation Therapy (SBRT) in Lung Cancer2021
Nittala MR, Mundra EK, Packianathan S, Shultz GL, Woods WC, Smith ML, Craft BS, Vijayakumar S Ductal Carcinoma in Situ (DCIS) of the Breast: Impact of Age, Grade, and Receptor Status on Survival2021
Nittala MR, Mundra EK, Smith ML, Woods WC, Hamilton R, Jefferson G, Jackson L, Vijayakumar S Improved Clinical Outcomes with Shorter Intervals between Surgery and Postoperative Radiotherapy in T4 Laryngeal Cancers International Journal of Radiation Oncology*Biology*Physics. 2020; 108(2); e402020
Nittala MR, Mundra EK, Smith ML, Woods WC, Hamilton R, Jefferson G, Jackson L, Packianathan S, Mehta D, Allbright R, Vijayakumar S. Impact of Race on Outcomes in T1 Glottic Cancer patients after Radiation Therapy (RT) International Journal of Radiation Oncology*Biology*Physics. 2020; 108(2): e482020

Journal Article

Nittala MR, Duggar WN, Mundra E, Packianathan S, Smith ML, Woods WC, Otts J, Bhandari R, Allbright R, De Delva PE, Moremen JR, Yang CC, Vijayakumar S, Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens. Cureus, 2021 Oct;13(10):e188622021
Nittala MR, Mundra EK, Packianathan S, Mehta D, Smith ML, Woods WC, McKinney S, Craft BS, Vijayakumar S, The Will Rogers phenomenon, breast cancer and race. BMC cancer, 2021 May 17;21(1):5542021
Nittala MR, Kanakamedala MR, Mundra E, Vengaloor Thomas T, Bhanat E, Woods WC 3rd, Vijayakumar S, Factors Affecting Outcomes in Patients With Stage III & IV Squamous Cell Carcinoma of Oropharynx: The Importance of p16 Status, BMI, and Race. Cureus, 2021 Mar 3;13(3):e136742021
Nittala MR, Kanakamedala MR, Mundra E, Woods WC 3rd, Smith ML, Hamilton RD, Jefferson GD, Jackson L, Packianathan S, Vijayakumar S, Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma. Cureus, 2021 Jan 30;13(1):e130222021
Vengaloor Thomas T, Krishna K, Ahmed HZ, Mundra E, Abraham A, Bhanat E, Nittala MR, Packianathan S, Vijayakumar S, A 25-year Experience at an Academic Medical Center in the United States: Are There Racial Disparities in the Prognosis of Patients Diagnosed With Hypopharyngeal Carcinoma? Cureus, 2020 Nov 3;12(11):e113062020

Abstracts

Nittala MR, Mundra EK, King ML, Albert A, Woods WC, Smith ML, Hamilton RD, Jackson L, Jefferson G, Packianathan S, Manucha V, Vijayakumar S Impact of race on outcomes in oropharyngeal squamous-cell carcinoma patients with known HPV/p16 status Cancer Epidemiol Biomarkers Prev. 2020; 29(12): PO-1042020
Nittala MR, Packianathan S, Mundra EK, King ML, Gandhi S, Allbright RM, Smith ML, Woods WC, Thomas TV, Ridgway R, Vijayakumar S. Improved clinical outcomes with shorter intervals between concurrent chemoradiation and brachytherapy in FIGO IB2-IVA cervical cancer patients among a predominantly African-American population Cancer Epidemiol Biomarkers Prev. 2020; 29(12): Abstract nr PO-2302020
Nittala MR, Mundra EK, Albert A, Woods WC, Smith ML, Hamilton RD, Jackson L, Jefferson G, Packianathan S, Bhanat E, Manucha V, Vijayakumar S Univariate and multivariate prognostic factors for overall survival among oropharyngeal cancer patients with known HPV/p16 status Cancer Epidemiol Biomarkers Prev. 2020; 29(12): Abstract nr PO-2322020
Nittala MR, Packianathan S, Mundra EK, King ML, Gandhi S, Allbright RM, Smith ML, Woods WC, Thomas TV, Ridgway M, Vijayakumar S Survival and Local Control Among African-Americans and Caucasians Following Treatment of Cervix Cancer in a University Medical Center International Journal of Radiation Oncology *Biology *Physics. 2020; 108(3): e4962020
Nittala MR, Mundra EK, Packianathan S, Mehta D, Smith ML, Woods WC, McKinney S, Craft BS, Vijayakumar S. Triple negative breast cancer patients treated with radiation therapy: Improvement in survival and local control with adjuvant chemotherapy compared to neoadjuvant chemotherapy Cancer Research. 2020; 80(16); Abstract nr 61772020
Nittala MR, Kanakamedala MR, Mundra E, Vijayakumar S. Qalys and dalys are better with concurrent chemoRT than induction chemo followed by chemoRT in nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev. 2020; 29(6): Abstract nr B1262020
Nittala MR, Mundra EK, Packianathan S, Mehta D, Woods WC, Mckinney S, Craft BS, Vijayakumar S The Will Rogers Phenomenon in breast cancer: The AJCC 8th Ed. and the importance of caution in the interpretation of outcomes differences for overall
population and race-specific cohorts.
Cancer Epidemiology, Biomarkers & Prevention. 2020; 29(6): Abstract nr B126
2020

Presentations

Platform Presentations, Role of radiotherapy in low grade gliomas, UNOS, UMMC, UMMC11/2021
Department lecture, re-irradiation in Head and neck cancer, UMMC Radiation Oncology, Radiation Oncology08/2020
Platform Presentations, Total body radiotherapy, UMMC Radiation Physicis, Radiation Oncology10/2018
UMMC Radiology ground rounds 2016, using of imaging in cervical cancer staging, UMMC, UMMC Student health building05/2016

Honors, Awards, and Recognition

Board Certified Radiation Oncologist, DABR2022
Best Teacher in Radiation Oncology, UMMC2021
Best Teacher in Radiation Oncology, UMMC2020

Professional Membership and Service

American Brachytherapy Society, Member2021 - Present
Radiosurgery Society, Member2020 - Present
International Stereotactic Radiosurgery, Member2020 - Present
Association of Residents in Radiation Oncology, Member2019 - Present
Gamma Knife Radiosurgery Society, Member2019 - Present
American Society of Radiation Oncology, Member2016 - Present

Directed Student Learning

teacher2009 - 2014
Mentor2006 - 2007

Fellows supervised

Radiation Oncology, Attending Physician, 1 fellows supervised, rotation06/2022 - 07/2022

Residency Training

radiation oncology, Attending Physician2022 - 09/2022
Radiation Oncology, Attending Physician2022 - 05/2022